DUBLIN--(BUSINESS WIRE)--The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering.

GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, announced that it has received a milestone ...

According to Nova One Advisor, the global antibody drug conjugates market size is calculated at USD 16.14 billion in 2025 and ...

DUBLIN--(BUSINESS WIRE)--The "Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029" report has been added to ResearchAndMarkets.com ...

Clear vials of medicine with blue caps Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates. Treatment with ...

Antibody-drug conjugates (ADCs) have revolutionized the oncology field, offering targeted cancer treatments that improve efficacy without adversely affecting healthy cells. 1 ADCs’ potential extends ...

Gynecological cancers remain a major threat to women's health, with traditional therapies often having limited effect and ...

The "Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's offering.

Researchers have developed a calcium-activated delivery system that improves how antibody–drug conjugates penetrate tumor ...

Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.